Liang Lin
Director/Board Member chez Shenzhen Ionova Life Sciences Co., Ltd.
Profil
Liang Lin is a professional with experience in various directorial positions.
Currently, he holds directorial positions at Dizal Pharma, Shenzhen Ionova Life Sciences Co., Ltd., and Acerand Therapeutics Ltd.
In the past, he has worked as a Director at Shenyang Xingqi Pharmaceutical Co., Ltd., Sansure Biotech, Inc., and Dizal (Jiangsu) Pharmaceutical Co., Ltd.
He has also served as a Non-Executive Director at CanSino Biologics, Inc. Additionally, he worked as a Manager-Business Development at GlaxoSmithKline (China) Investment Co., Ltd.
Mr. Lin holds an MBA from China Europe International Business School and undergraduate and graduate degrees from China Pharmaceutical University.
Postes actifs de Liang Lin
| Sociétés | Poste | Début |
|---|---|---|
Shenzhen Ionova Life Sciences Co., Ltd.
 Shenzhen Ionova Life Sciences Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Ionova Life Sciences Co., Ltd. develops anti-tumor drugs. The private company is based in Shenzhen, China. | Director/Board Member | - |
Acerand Therapeutics Ltd.
 Acerand Therapeutics Ltd. BiotechnologyHealth Technology Acerand Therapeutics Ltd. discovers and develops small molecule drugs for cancer treatment. The private company is based in Pudong, China. | Director/Board Member | - |
Dizal Pharma
 Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Director/Board Member | - |
Anciens postes connus de Liang Lin
| Sociétés | Poste | Fin |
|---|---|---|
| CANSINO BIOLOGICS INC. | Director/Board Member | 21/02/2024 |
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Director/Board Member | 06/09/2023 |
| SANSURE BIOTECH INC. | Director/Board Member | 01/07/2022 |
| SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. | Director/Board Member | 06/01/2021 |
GlaxoSmithKline (China) Investment Co., Ltd.
 GlaxoSmithKline (China) Investment Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (China) Investment Co., Ltd. researches, develops, and wholesales pharmaceuticals, vaccines, and consumer healthcare products. The private company is based in Beijing, China. | Corporate Officer/Principal | 01/04/2010 |
Formation de Liang Lin
| China Europe International Business School | Masters Business Admin |
| China Pharmaceutical University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. | Health Technology |
| CANSINO BIOLOGICS INC. | Health Technology |
| SANSURE BIOTECH INC. | Health Technology |
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Commercial Services |
| Entreprise privées | 4 |
|---|---|
GlaxoSmithKline (China) Investment Co., Ltd.
GlaxoSmithKline (China) Investment Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (China) Investment Co., Ltd. researches, develops, and wholesales pharmaceuticals, vaccines, and consumer healthcare products. The private company is based in Beijing, China. | Health Technology |
Dizal Pharma
Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Health Technology |
Shenzhen Ionova Life Sciences Co., Ltd.
Shenzhen Ionova Life Sciences Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Ionova Life Sciences Co., Ltd. develops anti-tumor drugs. The private company is based in Shenzhen, China. | Health Technology |
Acerand Therapeutics Ltd.
Acerand Therapeutics Ltd. BiotechnologyHealth Technology Acerand Therapeutics Ltd. discovers and develops small molecule drugs for cancer treatment. The private company is based in Pudong, China. | Health Technology |
